Concepedia

Chukiat Sirivichayakul

CS

Statistics

Publications

44

Citations

3.4K

H-Index

27

Active since

1999

Affiliations

Mahidol University(Current)

Mahidol Oxford Tropical Medicine Research Unit

Ministry of Public Health

Research Institute for Tropical Medicine

Takeda (Switzerland)

Chukiat Sirivichayakul is an author at Mahidol University specializing in medicine, vaccination, and pediatrics.

ORCID

Top concepts

Publications per year

1999–2024

44

Publications

44

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. · The Lancet · 2012 · 805 citations

, , +8

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 357 citations · Full text

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas et al. · The Lancet · 2020 · 237 citations

, , +5

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

Luis Rivera, Shibadas Biswal, Xavier Sáez‐Llorens et al. · Clinical Infectious Diseases · 2021 · 226 citations · Full text

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Vianney Tricou, Delia Yu, Humberto Reynales et al. · The Lancet Global Health · 2024 · 189 citations · Full text

1–5 of 44